Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Donald

Showing results (681-690 of 721) with videos related to

Pageof 73
Sort By:
European Heart Journal. Cardiovascular Pharmacotherapy|February 1, 2018
Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLEShinya Goto, Peter Merrill, Lars Wallentin, et al.
Developmental Cognitive Neuroscience|June 6, 2022
The developing brain structural and functional connectome fingerprintJudit Ciarrusta, Daan Christiaens, Sean P Fitzgibbon, et al.
Stroke|June 20, 2018
Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES TrialK S Lawrence Wong, Pierre Amarenco, Gregory W Albers, et al.
Circulation|June 29, 2017
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)J Donald Easton, Maria Aunes, Gregory W Albers, et al.
The Lancet. Neurology|February 28, 2017
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trialPierre Amarenco, Gregory W Albers, Hans Denison, et al.
Stroke|July 20, 2017
Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined SourcePierre Amarenco, Gregory W Albers, Hans Denison, et al.
Circulation|October 8, 2008
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular riskJohn W Eikelboom, Graeme J Hankey, Jim Thom, et al.
American Heart Journal|March 10, 2010
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationaleRenato D Lopes, John H Alexander, Sana M Al-Khatib, et al.
Journal of the American Medical Informatics Association : JAMIA|January 25, 2024
Harnessing the potential of large language models in medical education: promise and pitfallsTrista M Benítez, Yueyuan Xu, J Donald Boudreau, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 15, 2023
Colchicine in High-risk Patients with Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3): Rationale and design of a multicenter randomized placebo-controlled trialYongjun Wang, Jiejie Li, S Claiborne Johnston, et al.
Pageof 73

Showing results (681-690 of 721) with videos related to

Sort By:
Pageof 73
European Heart Journal. Cardiovascular Pharmacotherapy|February 1, 2018
Antithrombotic therapy use and clinical outcomes following thrombo-embolic events in patients with atrial fibrillation: insights from ARISTOTLEShinya Goto, Peter Merrill, Lars Wallentin, et al.
Developmental Cognitive Neuroscience|June 6, 2022
The developing brain structural and functional connectome fingerprintJudit Ciarrusta, Daan Christiaens, Sean P Fitzgibbon, et al.
Stroke|June 20, 2018
Efficacy and Safety of Ticagrelor in Relation to Aspirin Use Within the Week Before Randomization in the SOCRATES TrialK S Lawrence Wong, Pierre Amarenco, Gregory W Albers, et al.
Circulation|June 29, 2017
Risk for Major Bleeding in Patients Receiving Ticagrelor Compared With Aspirin After Transient Ischemic Attack or Acute Ischemic Stroke in the SOCRATES Study (Acute Stroke or Transient Ischemic Attack Treated With Aspirin or Ticagrelor and Patient Outcomes)J Donald Easton, Maria Aunes, Gregory W Albers, et al.
The Lancet. Neurology|February 28, 2017
Efficacy and safety of ticagrelor versus aspirin in acute stroke or transient ischaemic attack of atherosclerotic origin: a subgroup analysis of SOCRATES, a randomised, double-blind, controlled trialPierre Amarenco, Gregory W Albers, Hans Denison, et al.
Stroke|July 20, 2017
Ticagrelor Versus Aspirin in Acute Embolic Stroke of Undetermined SourcePierre Amarenco, Gregory W Albers, Hans Denison, et al.
Circulation|October 8, 2008
Incomplete inhibition of thromboxane biosynthesis by acetylsalicylic acid: determinants and effect on cardiovascular riskJohn W Eikelboom, Graeme J Hankey, Jim Thom, et al.
American Heart Journal|March 10, 2010
Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationaleRenato D Lopes, John H Alexander, Sana M Al-Khatib, et al.
Journal of the American Medical Informatics Association : JAMIA|January 25, 2024
Harnessing the potential of large language models in medical education: promise and pitfallsTrista M Benítez, Yueyuan Xu, J Donald Boudreau, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|April 15, 2023
Colchicine in High-risk Patients with Acute Minor-to-moderate Ischemic Stroke or Transient Ischemic Attack (CHANCE-3): Rationale and design of a multicenter randomized placebo-controlled trialYongjun Wang, Jiejie Li, S Claiborne Johnston, et al.
Pageof 73